These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 18327682)
1. Atypical localization of Leishmaniasis in an intestinal polyp. Zaffiri L; d'Ettorre G; Massetti AP; Mascellino MT; Mastroianni CM; Vullo V Infection; 2008 Mar; 36(2):187-8. PubMed ID: 18327682 [No Abstract] [Full Text] [Related]
2. Intestinal leishmaniasis in a patient with AIDS. Kostiuk O; Levi I; Krieger M; Assouline-Dayan Y; Barshack I Isr Med Assoc J; 2006 Oct; 8(10):714-5. PubMed ID: 17125123 [No Abstract] [Full Text] [Related]
4. A Traveler's Unwanted Souvenir. Challener D; Abu Saleh O Am J Med; 2018 Apr; 131(4):e137-e138. PubMed ID: 29031592 [No Abstract] [Full Text] [Related]
5. Recurrences of visceral leishmaniasis caused by Leishmania siamensis after treatment with amphotericin B in a seronegative child. Osatakul S; Mungthin M; Siripattanapipong S; Hitakarun A; Kositnitikul R; Naaglor T; Leelayoova S Am J Trop Med Hyg; 2014 Jan; 90(1):40-2. PubMed ID: 24277788 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of intestinal parasitosis]. Fossati C Clin Ter; 1975 Oct; 75(1):65-85. PubMed ID: 776504 [No Abstract] [Full Text] [Related]
7. Mucosal leishmaniasis in a Sudanese patient. Abbas K; Musatafa MA; Abass S; Kheir MM; Mukhtar M; Elamin EM; Elhassan AM Am J Trop Med Hyg; 2009 Jun; 80(6):935-8. PubMed ID: 19478252 [TBL] [Abstract][Full Text] [Related]
8. The pharmacology of leishmaniasis. Balaña-Fouce R; Reguera RM; Cubría JC; Ordóñez D Gen Pharmacol; 1998 Apr; 30(4):435-43. PubMed ID: 9580315 [TBL] [Abstract][Full Text] [Related]
9. Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B. Rongioletti F; Cannata GE; Parodi A Eur J Dermatol; 2009; 19(3):281-2. PubMed ID: 19286487 [No Abstract] [Full Text] [Related]
10. [Intestinal and hepatic parasitic diseases: diagnosis and treatment]. Gétaz L; Chappuis F; Loutan L Rev Med Suisse; 2007 May; 3(111):1254-8. PubMed ID: 17585630 [TBL] [Abstract][Full Text] [Related]
11. Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B. Amato VS; Tuon FF; Campos A; Bacha HA; Nicodemo AC; Amato Neto V; Shikanai-Yasuda MA Clin Infect Dis; 2007 Jan; 44(2):311-2. PubMed ID: 17173238 [No Abstract] [Full Text] [Related]
12. [Intestinal parasitic diseases--diagnosis and therapy]. Schubert S Z Arztl Fortbild (Jena); 1991 May; 85(9):431-5. PubMed ID: 1853630 [No Abstract] [Full Text] [Related]
15. ABLE: a new and improved amphotericin B for visceral leishmaniasis? Berman J Am J Trop Med Hyg; 2009 May; 80(5):689-90. PubMed ID: 19407106 [No Abstract] [Full Text] [Related]
16. Visceral leishmaniasis caused by Leishmania infantum in Thailand. Maharom P; Siripattanapipong S; Mungthin M; Naaglor T; Sukkawee R; Pudkorn R; Wattana W; Wanachiwanawin D; Areechokchai D; Leelayoova S Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):988-90. PubMed ID: 19062685 [TBL] [Abstract][Full Text] [Related]